NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

>>But in an unlikely move, in fall 2024, Merck & Co. decided to acquire Modifi Biosciences in a $1.3 billion deal. While a pharmaceutical giant like Merck would not be typically interested in a drug still in its early stages of development like KL-50, its unique mechanism and potential to also treat other kinds of cancers had caught the company’s attention. In its hands, if all runs smoothly, Bindra says KL-50 could become available to patients as early as next year.

https://medicine.yale.edu/news-article/for-families-battling-brain-cancer-new-treatment-brings-hope/